HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

δ-opioid receptor activation and microRNA expression of the rat cortex in hypoxia.

Abstract
Prolonged hypoxic/ischemic stress may cause cortical injury and clinically manifest as a neurological disability. Activation of the δ-opioid receptor (DOR) may induce cortical protection against hypoxic/ischemic insults. However, the mechanisms underlying DOR protection are not clearly understood. We have recently found that DOR activation modulates the expression of microRNAs (miRNAs) in the kidney exposed to hypoxia, suggesting that DOR protection may involve a miRNA mechanism. To determine if the miRNAs expressed in the cortex mediated DOR neuroprotection, we examined 19 miRNAs that were previously identified as hypoxia- and DOR-regulated miRNAs in the kidney, in the rat cortex treated with UFP-512, a potent and specific DOR agonist under hypoxic condition. Of the 19 miRNAs tested, 17 were significantly altered by hypoxia and/or DOR activation with the direction and amplitude varying depending on hypoxic duration and times of DOR treatment. Expression of several miRNAs such as miR-29b, -101b, -298, 324-3p, -347 and 466b was significantly depressed after 24 hours of hypoxia. Similar changes were seen in normoxic condition 24 hours after DOR activation with one-time treatment of UFP-512. In contrast, some miRNAs were more tolerant to hypoxic stress and showed significant reduction only with 5-day (e.g., miR-31 and -186) or 10-day (e.g., miR-29a, let-7f and -511) exposures. In addition, these miRNAs had differential responses to DOR activation. Other miRNAs like miRs-363* and -370 responded only to the combined exposure to hypoxia and DOR treatment, with a notable reduction of >70% in the 5-day group. These data suggest that cortical miRNAs are highly yet differentially sensitive to hypoxia. DOR activation can modify, enhance or resolve the changes in miRNAs that target HIF, ion transport, axonal guidance, free radical signaling, apoptosis and many other functions.
AuthorsYilin Yang, Feng Zhi, Xiaozhou He, Meredith L Moore, Xuezhi Kang, Dongman Chao, Rong Wang, Dong H Kim, Ying Xia
JournalPloS one (PLoS One) Vol. 7 Issue 12 Pg. e51524 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID23272113 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • 2',6'-dimethyltyrosyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (1H-benzimidazol-2-yl)(carboxymethyl)methylamide
  • Benzimidazoles
  • MicroRNAs
  • Neuroprotective Agents
  • Oligopeptides
  • Receptors, Opioid, delta
Topics
  • Animals
  • Apoptosis
  • Benzimidazoles (pharmacology)
  • Cerebral Cortex (metabolism)
  • Hypoxia (metabolism)
  • Ischemia (metabolism)
  • Kidney (metabolism)
  • Male
  • MicroRNAs (metabolism)
  • Neuroprotective Agents (metabolism)
  • Oligonucleotide Array Sequence Analysis
  • Oligopeptides (pharmacology)
  • Polymerase Chain Reaction (methods)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Opioid, delta (metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: